Banx Media Platform logo
TECHNOLOGYSocial MediaAR/VRGamingHappening Now

Bilibili, China’s Alternative to YouTube, Expands Internationally

Chinese video platform Bilibili is accelerating its global expansion, targeting overseas viewers with licensed content, creators, and localized services.

J

Julie

BEGINNER
5 min read
0 Views
Credibility Score: 84/100
Bilibili, China’s Alternative to YouTube, Expands Internationally

Bilibili, a Chinese video-sharing platform often compared with YouTube, is expanding its international presence as it seeks new audiences and revenue sources. The company is promoting licensed entertainment, user-generated videos, animation, gaming content, and creator partnerships in overseas markets. Its strategy includes adapting content and services to local preferences while using its strong community features to attract younger viewers. The expansion comes as competition intensifies among global streaming platforms and Chinese technology companies look abroad for growth beyond their domestic market.

Note: This article was published on BanxChange.com and is powered by the BXE Token on the XRP Ledger. For the latest articles and news, please visit BanxChange.com

Decentralized Media

Powered by the XRP Ledger & BXE Token

This article is part of the XRP Ledger decentralized media ecosystem. Become an author, publish original content, and earn rewards through the BXE token.

Newsletter

Stay ahead of the news — and win free BXE every week

Subscribe for the latest news headlines and get automatically entered into our weekly BXE token giveaway.

No spam. Unsubscribe anytime.

Share this story

Help others stay informed about crypto news

Related articles

Keep exploring the latest stories.

View more
Across Singapore’s Financial Landscape, New Incentives Seek to Keep Global Funds and Talent Moving Toward The City

Across Singapore’s Financial Landscape, New Incentives Seek to Keep Global Funds and Talent Moving Toward The City

Singapore plans new tax and visa incentives to strengthen its fund-management sector as competition with other Asian financial hubs intensifies.

. When Molecular Messages Meet Melanoma: Moderna and Merck Open Another Door Toward Personalized Cancer Care

. When Molecular Messages Meet Melanoma: Moderna and Merck Open Another Door Toward Personalized Cancer Care

Moderna and Merck reported positive late-stage results for a personalized mRNA vaccine combined with Keytruda against melanoma recurrence.

When Personalized Vaccines Meet Cancer, A New Chapter Opens Between Molecular Science and the Human Immune System

When Personalized Vaccines Meet Cancer, A New Chapter Opens Between Molecular Science and the Human Immune System

Moderna and Merck reported positive late-stage results for a personalized mRNA vaccine that reduced melanoma recurrence and spread.